Trial · NCT03094416
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Thyroid Stimulating Hormone (TSH) | baseline and 12 weeks | Change in Serum Levels of TSH (Thyroid Stimulating Hormone) from Baseline |
| Secondary | Free Thyroxine (FT4) | baseline and 12 weeks | Change in Serum Levels of FT4 (free thyroxine) from Baseline |
| Secondary | Total Thyroxine (TT4) | baseline and 12 weeks | Change in Serum Levels of TT4 (total thyroxine) from Baseline |
| Secondary | Free Triiodothyronine (FT3) | baseline and 12 weeks | Change in Serum Levels of FT3 (free triiodothyronine) from Baseline |
| Secondary | Total Triiodothyronine (TT3) | baseline and 12 weeks | Change in Serum Levels of TT3 (total triiodothyronine) from Baseline |
| Other | Creatine Phosphokinase (CPK) | baseline and 12 weeks | Change in Serum Levels of creatine phosphokinase (CPK) from Baseline |
| Other | Sex Hormone Binding Globulin (SHBG) | baseline and 12 weeks | Change in Serum Levels of SHBG (sex hormone binding globuline) from Baseline |
| Other | Ferritin | baseline and 12 weeks | Change in Serum Levels of ferritin from Baseline |
| Other | Angiotensin Converting Enzyme (ACE) | baseline and 12 weeks | Change in Serum Levels of ACE (angiotensin converting enzyme) from Baseline |
| Other | Triglycerides | baseline and 12 weeks | Change in triglycerides levels from Baseline |
| Other | Cholesterol, Total | baseline and 12 weeks | Change in total cholesterol levels from Baseline |
| Other | Low Density Lipoprotein (LDL)-Cholesterol | baseline and 12 weeks | Change in low density lipoprotein (LDL)-cholesterol levels from baseline |
| Other | High Density Lipoprotein (HDL)-Cholesterol | baseline and 12 weeks | Change in High Density Lipoprotein (HDL)-cholesterol levels from baseline |
| Other | Very Low Density Lipoprotein (VLDL)-Cholesterol | baseline and 12 weeks | Change in Very Low Density Lipoprotein (VLDL)-cholesterol levels from baseline |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03094416/registered